Pfizer Statistics
Total Valuation
Pfizer has a market cap or net worth of THB 4.33 trillion. The enterprise value is 5.80 trillion.
Market Cap | 4.33T |
Enterprise Value | 5.80T |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025.
Earnings Date | Aug 5, 2025 |
Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.92% |
Shares Change (QoQ) | -0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 5.68B |
Valuation Ratios
The trailing PE ratio is 12.36 and the forward PE ratio is 8.40.
PE Ratio | 12.36 |
Forward PE | 8.40 |
PS Ratio | 2.08 |
PB Ratio | 1.49 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.86, with an EV/FCF ratio of 14.31.
EV / Earnings | 16.56 |
EV / Sales | 2.81 |
EV / EBITDA | 6.86 |
EV / EBIT | 9.87 |
EV / FCF | 14.31 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.69.
Current Ratio | 1.16 |
Quick Ratio | 0.78 |
Debt / Equity | 0.69 |
Debt / EBITDA | 2.38 |
Debt / FCF | 4.97 |
Interest Coverage | 5.84 |
Financial Efficiency
Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.31%.
Return on Equity (ROE) | 12.17% |
Return on Assets (ROA) | 5.34% |
Return on Invested Capital (ROIC) | 7.31% |
Return on Capital Employed (ROCE) | 10.72% |
Revenue Per Employee | 25.67M |
Profits Per Employee | 4.32M |
Employee Count | 81,000 |
Asset Turnover | 0.30 |
Inventory Turnover | 1.42 |
Taxes
Income Tax | -7.66B |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 15.90 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 39.43 |
Average Volume (20 Days) | 81,266 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pfizer had revenue of THB 2.08 trillion and earned 350.29 billion in profits. Earnings per share was 61.71.
Revenue | 2.08T |
Gross Profit | 1.55T |
Operating Income | 588.15B |
Pretax Income | 343.15B |
Net Income | 350.29B |
EBITDA | 808.71B |
EBIT | 588.15B |
Earnings Per Share (EPS) | 61.71 |
Balance Sheet
The company has 431.64 billion in cash and 2.01 trillion in debt, giving a net cash position of -1,581.65 billion.
Cash & Cash Equivalents | 431.64B |
Total Debt | 2.01T |
Net Cash | -1,581.65B |
Net Cash Per Share | n/a |
Equity (Book Value) | 2.90T |
Book Value Per Share | 508.28 |
Working Capital | 194.72B |
Cash Flow
In the last 12 months, operating cash flow was 494.81 billion and capital expenditures -89.59 billion, giving a free cash flow of 405.22 billion.
Operating Cash Flow | 494.81B |
Capital Expenditures | -89.59B |
Free Cash Flow | 405.22B |
FCF Per Share | n/a |
Margins
Gross margin is 74.36%, with operating and profit margins of 28.28% and 16.84%.
Gross Margin | 74.36% |
Operating Margin | 28.28% |
Pretax Margin | 16.50% |
Profit Margin | 16.84% |
EBITDA Margin | 38.89% |
EBIT Margin | 28.28% |
FCF Margin | 19.49% |
Dividends & Yields
This stock pays an annual dividend of 0.24, which amounts to a dividend yield of 1.54%.
Dividend Per Share | 0.24 |
Dividend Yield | 1.54% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 89.68% |
Buyback Yield | -0.92% |
Shareholder Yield | 0.62% |
Earnings Yield | 8.09% |
FCF Yield | 9.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 8 |